• IP-MS Validated UBE2Q1 Polyclonal Antibody
    • Cat#: MSVAB-14909
    • Primary Applications: IP, Co-IP, IP-MS
    • Species Reactivity: Human
    • Antibody Specificity: UBE2Q1
    • Other Applications: ELISA

    Customer Support Program

    • First-time antibody customers may receive IP-MS identification for one sample at no additional cost with their first antibody purchase.
    • Customers who purchase antibodies may receive 10% off subsequent IP-MS identification services.
  • -
    1
    +
    Add to Cart

Target Information

Target informationUbiquitin-conjugating enzyme E2 Q1 (UBE2Q1), with aliases including GTAP and NICE5, is an E2 ubiquitin-conjugating enzyme implicated in cellular ubiquitination processes. UBE2Q1 is commonly studied in protein turnover, signaling regulation, ubiquitin-dependent proteostasis, and post-translational control of cellular protein networks. Its role as an E2 enzyme makes it relevant to studies of ubiquitin transfer and protein modification pathways. MtoZ Biolabs provides IP-MS Validated UBE2Q1 Polyclonal Antibody for enrichment of UBE2Q1-associated proteins before mass spectrometry-based analysis. This UBE2Q1 antibody validated by IP-MS is appropriate for examining ubiquitination pathway components, E2 enzyme interaction partners, and UBE2Q1-linked regulatory complexes. Projects requiring a UBE2Q1 IP antibody or a UBE2Q1 antibody for immunoprecipitation can use this product for target capture and downstream LC-MS/MS profiling.
Target nameubiquitin-conjugating enzyme E2Q family member 1
AliasesE2 ubiquitin-conjugating enzyme Q1, EC:2.3.2.23, GTAP, NICE 5, NICE5
UniProt accessionQ7Z7E8

Product Introduction

Primary applications
  • IP (Immunoprecipitation)
  • Co-IP (Co-Immunoprecipitation)
  • IP-MS (Immunoprecipitation-Mass Spectrometry)

Before delivery, each antibody undergoes IP-MS validation to verify its ability to recognize and enrich the intended target protein

Other applicationsELISA
Species reactivityHuman
ClonalityPolyclonal
HostRabbit
Recommended dilution ratioIP: 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Specification50 μL,100 μL,150 μL
Storage conditionShort-term storage at 2-8 °C. Long-term storage at -20 °C. Avoid repeated freeze-thaw cycles

MtoZ Biolabs IP-MS Workflow Products

MtoZ Biolabs offers a fully integrated IP-MS workflow solution, combining antibodies validated for IP-MS with expertly paired IP kits and seamless downstream mass spectrometry services. Our platform empowers researchers to achieve reliable target enrichment, protein interaction mapping, and comprehensive proteomic profiling with confidence and efficiency.

IP-MS Validated Antibodies

  • Antibodies rigorously tested for IP-MS applications
  • Minimize experimental uncertainty and accelerate research timelines
  • Broad applicability across multiple species and protein targets

Expertly Paired IP Kits

  • Designed and validated to complement MtoZ IP-MS antibodies
  • Detailed step-by-step experimental protocols for reproducible target enrichment
  • Optimized workflows to maximize antibody performance

Comprehensive IP-MS Analysis Services

  • Submit immunoprecipitated samples directly to MtoZ Biolabs
  • High-resolution mass spectrometry for target verification, interaction mapping, and proteomics studies
  • Structured, publication-ready reports for seamless documentation and data reproducibility

Antibody Validation Levels

To support different research goals, budgets, and evidence requirements, our antibodies are available with multiple validation levels. Each antibody undergoes IP-MS validation before delivery to confirm target-specific recognition and enrichment. For projects requiring additional confirmation, Western blot validation can be added to provide orthogonal evidence of target detection.

Validation levelIncluded validationBest for
IP-MS OnlyConfirms target-specific enrichment by immunoprecipitation followed by mass spectrometry analysis.IP-based protein enrichment and target specificity assessment.
Western Blot OnlyConfirms target detection by Western blot under defined experimental conditions.Routine target detection and expression-level assessment.
IP-MS + Western BlotCombines mass spectrometry-based target enrichment evidence with Western blot-based detection evidence.Customers requiring more comprehensive validation support.

Antibody Validation Workflow

https://file.brightmindcrm.com/dev/mtoz-product/20260522/article/2057637939214188544-20260521-161303.png

Validation Report Included

IP-MS

  • IP experiment record
  • Antibody usage information
  • Original experimental image
  • Mass spectrometry parameters
  • Identified target peptides
  • Representative MS/MS spectra

Western Blot

  • WB experimental conditions
  • Original blot image
  • Qualitative target band recognition result

MtoZ Biolabs IP-MS Antibody Solutions

Traditional Antibody Supplier

Conventional workflow
  • Customers need to purchase small amounts of antibody for in-house testing

    01
  • Validation depends on customer-provided samples and workflows

    02
  • Suppliers usually stop support after product delivery

    03
  • Customers must find a separate provider for MS or interaction analysis

    04
  • Higher risk of repeated trial-and-error

    05

MtoZ Biolabs IP-MS Antibody Solutions

Recommended
  • MtoZ Biolabs can provide IP-MS validation before or at the time of purchase

    01
  • Validation is supported by MS-based evidence and a detailed report

    02
  • Antibody purchase can be directly connected to downstream IP-MS services

    03
  • Antibody and downstream IP-MS analysis can be completed within a single workflow

    04
  • Reduces trial attempts and accelerates project progress

    05

Why Choose MtoZ Biolabs?

0+

Antibodies Validated

0+

Target Proteins

0+

Research Institutions Served

Full Validation Reports Included

Structured IP/Co-IP/IP-MS validation reports are included with every antibody for easy lab recordkeeping and project documentation.

Ultra-High Resolution MS Platform

IP-MS validation on high-resolution LC-MS/MS instrumentation for confident target enrichment and specificity assessment.

FAQ

IP-MS validation means that the antibody is first used to pull down proteins from a cell lysate, and the captured proteins are then analyzed by mass spectrometry. This helps confirm whether the antibody can recognize and enrich its intended target protein, instead of mainly pulling down unrelated background proteins.
IP-MS validation does not require a long additional wait. Based on our optimized workflow, it typically adds no more than 5 to 7 business days to the standard processing time. After validation is completed, the antibody and validation report are delivered together.
The validation report includes key experimental records, workflow details, antibody usage information, mass spectrometry settings, target protein identification results, and signal intensity evaluation. The report provides clear supporting data that customers can review and use for project documentation.
We use an ultra-high resolution mass spectrometry platform for IP-MS validation. This platform supports accurate protein identification and provides reliable peptide-level evidence for reviewing antibody validation results.
Submit Inquiry
Name *
Email Address *
Phone Number
Inquiry Project *
Project Description